changes in research to overcome the problem of resistance to new cll drugs
Published 7 years ago • 64 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
3:02
durability of response & biomarker changes in the manifest study
-
1:18
involving the patient in treatment decisions for cll
-
1:33
key factors affecting treatment decision making in cll
-
1:09
cll treatment: discussing new data from the last 3 years
-
5:21
examples of biology informing treatment decisions in cll
-
2:18
tools to improve the outcomes of patients with cll affected by covid-19
-
1:35
the future directions of cll research: mechanisms of pathogenesis and novel biomarkers
-
7:37
case study - time management issue
-
12:27
the genius algorithm behind dna error correction (tmeb #5)
-
13:24
chronic myeloid leukemia made easy
-
1:52
how point of care diagnostics will change health care
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:31
novel approaches to cll treatment
-
1:26
improving outcomes in sickle cell disease: expanding access and expediting treatment development
-
1:27
factors to consider in frontline and relapsed cll before treatment
-
14:43
current research into post-allosct maintenance therapy in aml
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
4:17
altered pathways as a biomarker for disease outcomes in cll
-
2:02
key questions about the future of cll
-
4:25
cll: state of the art in italy
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
2:20
overcoming lack of diversity in cancer clinical trials